| Bioactivity | Cergutuzumab is a fully human IgG1 antibody that targets CEACAM5. The isotype control for Cergutuzumab can refer to Human IgG1 kappa, Isotype Control (HY-P99001)[1]. |
| CAS | 1622305-37-6 |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Flisikowska T, et al. A humanized minipig model for the toxicological testing of therapeutic recombinant antibodies. Nat Biomed Eng. 2022 Nov;6(11):1248-1256. |